41 – 50 of 64
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Discovery of Dachshund 2 protein as a novel biomarker of poor prognosis in epithelial ovarian cancer
(
- Contribution to journal › Article
-
Mark
High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanoma
(
- Contribution to journal › Article
-
Mark
Molecular correlates and prognostic significance of SATB1 expression in colorectal cancer
(
- Contribution to journal › Article
-
Mark
Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer
(
- Contribution to journal › Article
-
Mark
Standard Guidelines for the Chromosome-Centric Human Proteome Project
(
- Contribution to journal › Article
-
Mark
The Chromosome-Centric Human Proteome Project for cataloging proteins encoded in the genome
(
- Contribution to journal › Letter
- 2011
-
Mark
High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progression.
(
- Contribution to journal › Article
-
Mark
Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: An analysis of 215 cases from the Malmo Diet and Cancer Study
(
- Contribution to journal › Article
-
Mark
Surrogate antigens as targets for proteome-wide binder selection
(
- Contribution to journal › Article
-
Mark
RBM3-Regulated Genes Promote DNA Integrity and Affect Clinical Outcome in Epithelial Ovarian Cancer.
(
- Contribution to journal › Article